CLINICAL FEATURES, EFFECTIVENESS OF THERAPY AND QUALITY OF LIFE OF PATIENTS WITH TYPE 2 DIABETES AND COMORBID SCHIZOPHRENIA ArticleArtemieva M., Varnakova T., Danilin I., Lazukova A., Suleimanov R., Sokolov V.European Psychiatry. Vol. 64. 2021.
IMPAIRED AGE SELF-CONSCIOUSNESS IN LATENT SCHIZOPHRENIA ArticleSuleimanov R., Artemieva M., Danilin I., Lazukova A., Sokolov V.European Psychiatry. Vol. 64. 2021.
LOW DOSE CHLORPROTHIXENE ADMINISTRATION IN PATIENTS WITH ATOPIC DERMATITIS ArticleDanilin I., Ziewozinska Z., Korsunskaya I., Artemieva M., Suleymanov R., Sokolov V., Karnozov V.European Psychiatry. Vol. 56. 2019.
ASSESMENT OF THE QUALITY OF TREATMENT IN PATIENTS WITH SOMATOFORM DISORDERS AT THE PREHOSPITAL LEVEL ArticleNavasardyan E., Artemieva M., Danilin I., Suleymanov R., Lazukova A., Belokrylov I., Sokolov V., Niewozinska Z.European Psychiatry. Vol. 56. 2019.
THE METHOD OF IMPROVING COMPLIANCE IN PATIENTS WITH SCHIZOPHRENIA ArticleBelokrylov I., Sokolov V., Bryukhin A.European Psychiatry. Vol. 48. 2018.